221 related articles for article (PubMed ID: 17525716)
21. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
Levy AP; Blum S
Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1105-11. PubMed ID: 18035926
[TBL] [Abstract][Full Text] [Related]
22. Haptoglobin: basic and clinical aspects.
Levy AP; Asleh R; Blum S; Levy NS; Miller-Lotan R; Kalet-Litman S; Anbinder Y; Lache O; Nakhoul FM; Asaf R; Farbstein D; Pollak M; Soloveichik YZ; Strauss M; Alshiek J; Livshits A; Schwartz A; Awad H; Jad K; Goldenstein H
Antioxid Redox Signal; 2010 Feb; 12(2):293-304. PubMed ID: 19659435
[TBL] [Abstract][Full Text] [Related]
23. Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque.
Moreno PR; Purushothaman KR; Purushothaman M; Muntner P; Levy NS; Fuster V; Fallon JT; Lento PA; Winterstern A; Levy AP
J Am Coll Cardiol; 2008 Sep; 52(13):1049-51. PubMed ID: 18848136
[TBL] [Abstract][Full Text] [Related]
24. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
25. Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.
Levy Y; Blum S; Levy AP
Clin Nutr; 2009 Oct; 28(5):581-2. PubMed ID: 19464773
[TBL] [Abstract][Full Text] [Related]
26. Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients.
Koda Y; Soejima M; Yamagishi S; Amano S; Okamoto T; Inagaki Y; Yamada K; Kimura H
Diabetologia; 2002 Jul; 45(7):1039-40. PubMed ID: 12187922
[No Abstract] [Full Text] [Related]
27. Haptoglobin polymorphism and diabetic nephropathy in Brazilian diabetic patients.
Wobeto VP; Garcia PM; Zaccariotto TR; Sonati Mde F
Ann Hum Biol; 2009; 36(4):437-41. PubMed ID: 19455468
[TBL] [Abstract][Full Text] [Related]
28. Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene.
Levy AP
Acta Diabetol; 2003 Dec; 40 Suppl 2():S330-3. PubMed ID: 14704863
[TBL] [Abstract][Full Text] [Related]
29. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.
Goldenstein H; Levy NS; Levy AP
Pharmacol Res; 2012 Jul; 66(1):1-6. PubMed ID: 22465143
[TBL] [Abstract][Full Text] [Related]
30. Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility.
Conway BR; Savage DA; Brady HR; Maxwell AP
Nephron Exp Nephrol; 2007; 105(3):e75-9. PubMed ID: 17220636
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability.
Levy AP; Purushothaman KR; Levy NS; Purushothaman M; Strauss M; Asleh R; Marsh S; Cohen O; Moestrup SK; Moller HJ; Zias EA; Benhayon D; Fuster V; Moreno PR
Circ Res; 2007 Jul; 101(1):106-10. PubMed ID: 17525367
[TBL] [Abstract][Full Text] [Related]
32. Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques.
Lioupis C; Barbatis C; Drougou A; Koliaraki V; Mamalaki A; Klonaris C; Georgopoulos S; Andrikopoulos V; Bastounis E
Atherosclerosis; 2011 May; 216(1):131-8. PubMed ID: 21316675
[TBL] [Abstract][Full Text] [Related]
33. Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population.
Amor AJ; Canivell S; Oriola J; Ricart MJ; de Hollanda AM; Bosch-Comas A; Esmatjes E
Nefrologia; 2014; 34(2):212-5. PubMed ID: 24658196
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
[TBL] [Abstract][Full Text] [Related]
35. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?
Vardi M; Levy AP
Curr Diab Rep; 2012 Jun; 12(3):274-9. PubMed ID: 22427005
[TBL] [Abstract][Full Text] [Related]
36. The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and Mice.
Dahan I; Thawho N; Farber E; Nakhoul N; Asleh R; Levy AP; Li YC; Ben-Izhak O; Nakhoul F
J Diabetes Res; 2018; 2018():7163652. PubMed ID: 30250850
[TBL] [Abstract][Full Text] [Related]
37. Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans.
Park KU; Song J; Kim JQ
J Clin Pathol; 2004 Oct; 57(10):1094-5. PubMed ID: 15452167
[TBL] [Abstract][Full Text] [Related]
38. Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients.
Wang S; Wang J; Zhang R; Wang T; Yan D; He Z; Jiang F; Hu C; Jia W
Cardiovasc Diabetol; 2018 Jan; 17(1):14. PubMed ID: 29338727
[TBL] [Abstract][Full Text] [Related]
39. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.
Asleh R; Guetta J; Kalet-Litman S; Miller-Lotan R; Levy AP
Circ Res; 2005 Mar; 96(4):435-41. PubMed ID: 15662028
[TBL] [Abstract][Full Text] [Related]
40. Comment to: F. M. Nackhoul et al. (2001) Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44: 602-604.
Schaer DJ
Diabetologia; 2001 Nov; 44(11):2104-5. PubMed ID: 11719844
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
